Notice of Results
Cambridge Cognition Holdings plc
("Cambridge Cognition" or the "Company")
Notice of Preliminary Results Release
Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, will announce its preliminary results for the year ended 31 December 2021 on 12 April 2022 .
For further information, contact:
|
Cambridge Cognition Holdings Plc Matthew Stork, Chief Executive Officer Steven Powell, Chairman |
Tel: 012 2381 0700 |
|
Panmure Gordon (NOMAD and Joint Broker) Freddy Crossley / Emma Earl / Mark Rogers Rupert Dearden |
Tel: 020 7886 2500 (Corporate Advisory) (Corporate Broking) |
|
Dowgate Capital Limited (Joint Broker) David Poutney / James Serjeant |
Tel: 020 3903 7715
|
|
IFC Advisory Ltd (Financial PR and IR) Tim Metcalfe / Graham Herring / Zach Cohen |
Tel: 020 3934 6630
|
Notes to Editors
About Cambridge Cognition
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
For further information visit www.cambridgecognition.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 hour ago Alphawave IP Group
- 2 hours ago WH Smith
- 2 hours ago Staffline Group
- 3 hours ago Manchester & London Investment Trust
- 3 hours ago Associated British Foods